Related Experiment Videos
The influence of endocardial endothelium on myocardial contraction
1Department of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff, UK.
Trends in Pharmacological Sciences
|March 1, 1992
Insights
Researchers discovered endocardin, a new agent from the heart
Area of Science:
- Cardiovascular Physiology
- Endothelial Biology
- Molecular Cardiology
Background:
- The endocardial endothelium plays a crucial role in regulating cardiac function.
- Distinct factors released by the endothelium influence myocardial contractility.
Purpose of the Study:
- To investigate the properties and effects of a novel agent, endocardin, released from the endocardial endothelium.
- To compare the actions of endocardin with endothelium-derived relaxing factor (EDRF).
Main Methods:
- Identification and characterization of endocardin.
- Experimental analysis of the effects of endocardin and EDRF on myocardial contraction.
- Discussion of proposed mechanisms of action.
Main Results:
- A novel agent, endocardin, is released from the endocardial endothelium.
- Endocardin prolongs myocardial contraction.
- Endothelium-derived relaxing factor abbreviates myocardial contraction.
Conclusions:
- Endocardin and EDRF exert opposing effects on myocardial contractility.
- These findings suggest distinct roles for endocardial endothelium-derived factors in cardiac regulation.
- Further research is needed to elucidate the physiological and pathophysiological significance of endocardin.
Abstract:
A novel unidentified agent, provisionally named 'endocardin', has been shown to be released from endocardial endothelium. Endocardin has a unique prolonging effect on myocardial contraction. In contrast, endothelium-derived relaxing factor released from endocardial endothelium has the opposite effect of abbreviating contraction. Jerry Smith and colleagues discuss the mechanisms of action of these agents and their possible physiology and pathophysiology.